BV BrightView Holdings, Inc. Insider Trading

Director Cornog buys 5.0K BV shares at $13.46; second buy in 2 months amid 24.91 P/E and -$15.2M net loss.

Director William L. Cornog purchased 5,000 shares of BrightView Holdings at $13.46 on 2026-02-06, bringing his holdings to 5,000 shares. This is his second buy in the past two months—following a purchase at $13.46 on 2025-12-02—suggesting continued interest in the stock at current price levels. At his cross-ticker track record level, Cornog has achieved a 100.00% 90d win rate across 5 prior buys with an average 90d return of +16.4%, but his BrightView-specific history is more mixed: of 4 prior trades at BV, only 1 showed a well-timed 90d outcome (+18.2% on the 2025-02-21 buy), while his most recent prior buy on 2025-12-02 has returned -1.3% over 30 days. BrightView's fundamentals remain strained: the company reported net income of -$15.2M on revenue of $614.7M, trades at a P/E of 24.91, and faces annual revenue decline of -3.4%, suggesting Cornog's repeated purchases may reflect either conviction at current valuations or simply continued participation within a portfolio position regardless of operational trends.

Director Cornog buys 10,000 BV shares at $12.84; stake grows 50% to 30,000 shares

Director William L Cornog purchased 10,000 shares of BrightView Holdings at $12.84, doubling his stake from 20,000 to 30,000 shares (+50.0% increase in holdings). The purchase occurs with the stock trading -28.6% from its 52-week high of $17.89, and notably, Cornog's cross-ticker track record shows 4 prior open-market buys with a 100.00% 90-day win rate and average 90-day return of +16.4%. At BrightView specifically, his prior February 2025 purchase delivered a +18.2% 90-day return, suggesting selectivity in timing at this ticker. However, the company faces near-term headwinds: annual revenue declined -3.4% year-over-year, and the stock has fallen -11.4% over the past 90 days, trading at a P/E of 27.78 against $32.3M net income on $708.3M revenue. The insider's substantial share accumulation into this near-52-week-low price point, combined with his demonstrated historical accuracy on 90-day outcomes, represents a material conviction signal, though the negative revenue trajectory and elevated valuation multiple warrant scrutiny on fundamental stabilization.

CHRO Amanda Marie sold 70,000 BV shares (64.5% of holdings) at $14.78; stock down 8.7% in 30 days, now -20.8% from 52-week high.

Amanda Marie, EVP & CHRO at BrightView Holdings, executed a substantial sale of 70,000 shares on 2025-08-25, reducing her holdings by 64.5% from 108,446 to 38,446 shares. The sale came as the stock has declined 8.7% over the past 30 days and trades 20.8% below its 52-week high of $18.73, suggesting the executive liquidated a significant portion of her position in a downtrend. BrightView's fundamentals show modest stress: annual revenue declined 1.7% year-over-year, net income is $32.3M on revenue of $708.3M, and the stock carries a P/E of 26.04 relative to a $1.4B market cap. The large reduction in Marie's ownership stake, combined with the current price weakness and revenue contraction, warrants attention to whether additional insider activity or broader capital allocation changes may follow.

CFO Urban Brett Nicholas sold 77,419 shares (-84.5% of holdings) for $1,127,448.26 across two transactions on Aug 25-26

Urban Brett Nicholas, BrightView's CFO, executed two separate sales on August 25-26, 2025, totaling 77,419 shares for $1,127,448.26 at an average price of $14.56 per share. This represents a dramatic reduction in his holdings from 91,631 shares to 14,212 shares, a -84.5% decrease. The sales occurred while the stock was trading near its 52-week high of $18.73 (current price $14.84 is -20.8% from that peak), though notably the CFO sold at prices ($14.66 and $14.54) that were below current levels and well below the 52-week high. The company's fundamentals show a P/E of 26.04 on revenue of $708,300,000.00 and net income of $32,300,000.00, with annual revenue declining -1.7% year-over-year. This substantial liquidation of the CFO's position in a company with weakening revenue growth warrants investor attention to whether this reflects management's own assessment of valuation or capital allocation priorities.

KKR BrightView Aggregator sells 11,600,000 shares (11.60M) at $14.40; holder cuts stake by 35.0% to 21,533,123 shares

KKR BrightView Aggregator L.P., a 10% owner, conducted a substantial reduction of its position in BrightView Holdings, selling 11,600,000 shares at $14.40 for a total value of $167,040,000.00. The sale cut the insider's stake by 35.0%, from 33,133,123 shares to 21,533,123 shares—a material repositioning of a major shareholder's commitment to the company. The $14.40 execution price sits 12.8% below the 52-week high of $18.73, suggesting the transaction occurred during a relative pullback rather than at peak valuations. Against the broader context, BrightView's fundamentals show modest weakness (annual revenue growth of -1.7% and a high P/E of 34.74), which combined with this significant stake reduction by a major financial sponsor, warrants investor attention to whether this signal reflects KKR's reassessment of the company's trajectory or portfolio rebalancing driven by external capital allocation priorities.

KKR Group Partnership sold 11,600,000 shares of BV at $14.40 (−12.8% below 52-week high), reducing stake from 33.13M to 21.53M shares.

KKR Group Partnership, a 10% owner of BrightView, executed a single sale of 11,600,000 shares at $14.40 on 2025-06-06, cutting its position by 35.0% and raising $167,040,000. The sale occurred at a price 12.8% below the 52-week high of $18.73, in a market where BV has recovered 24.8% over 90 days. Operationally, BrightView faces headwinds: annual revenue declined 1.7% year-over-year, net income stands at only $6.4M on $662.6M in quarterly revenue (a 1.0% net margin), and the stock trades at a P/E of 34.74, well above historical norms for the sector. Across all prior open-market transactions, KKR's sells have been well-timed 50.00% of the time with an average 90-day return of +15.2%, providing limited signal on the quality of this specific timing.

Director Barker Kurtis T buys 40,000 shares of BV at $13.25; stock down -30.5% from 52-week high amid negative earnings.

Director Barker Kurtis T purchased 40,000 shares of BrightView Holdings at $13.25 on 2025-03-14, establishing an initial 40,000 share position. The transaction occurs in a deteriorated market environment: the stock trades at $13.02, down -30.5% from the 52-week high of $18.73 and off -19.2% over the past 90 days. Fundamentally, the company reported a net loss of $-10.4M in the latest quarter against revenue of $599.2M, with annual revenue declining -1.7% year-over-year. This insider purchase at a depressed valuation point, combined with the recent sharp price decline and ongoing operational losses, warrants monitoring of the company's financial trajectory and the director's conviction in a turnaround.

Director Cornog doubles BV stake to 20,000 shares at $13.50 as stock is -28.3% from 52-week high

William L Cornog, a director of BrightView Holdings, purchased 10,000 shares at $13.50 on 2025-02-21, doubling his holdings from 10,000 to 20,000 shares for a total value of $134,950.00. His prior two purchases at BV in 2023 both achieved positive 90-day returns (+17.7% and +17.5%), indicating a pattern of well-timed entries at this ticker. The current stock price of $13.43 sits -28.3% below the 52-week high of $18.73 and -15.3% over the past 30 days, providing a lower entry point than his 2023 purchases. However, the company's fundamentals show net income of -$10,400,000.00 against revenue of $599,200,000.00, with annual revenue declining -1.7% year-over-year, which tempers conviction signals that might otherwise accompany a director's purchase.